Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1101
Peer-review started: June 14, 2015
First decision: July 14, 2015
Revised: August 16, 2015
Accepted: November 9, 2015
Article in press: November 9, 2015
Published online: January 21, 2016
Processing time: 219 Days and 1.7 Hours
Surgery represents the main curative therapeutic modality for gastric cancer, and it is occasionally considered for palliation as well as prophylaxis. Most frequently, surgical outcomes are conveyed in terms of oncological outcomes such as recurrence and survival. However, quality of life (QoL) is also important and should be considered when making treatment decisions - including the extent of and approach to surgery. Measurement of QoL usually involves the application of questionnaires. While there are multiple QoL questionnaires validated for use in oncology patients, there are very few that have been validated for use in those with gastric cancer. In this review, we discuss and compare the current status of QoL questionnaires in gastric cancer. More importantly, the impact of surgery for treatment, palliation and prophylaxis of gastric cancer on QoL will be described. These data should inform the surgeon on the optimal approach to treating gastric cancer, taking into account oncological outcomes. Knowledge gaps are also identified, providing a roadmap for future studies.
Core tip: Quality of life is an important determinant in the optimal management of patients with malignancy. This is no different for gastric cancer where surgery is considered in cases of resection-for cure, palliation and prophylaxis. This review summarizes the available evidence surrounding the impact of surgery on quality of life in gastric cancer. In general, there has been an improved appreciation of the importance of quality of life as an outcome that must be considered in the context of survival and performance status.